Clear Street’s HCA Healthcare HCA Stock Holding History

Clear Street’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-20,000	Closed	-$6.07M	–	1188
2023 Q2	$6.07M	Buy	+20,000	New	+$5.56M	0.06%	168

Other funds holding HCA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Clear Street's HCA Position: Q3 2023 in Review

Clear Street sold out of HCA Healthcare (HCA) in Q3 2023, closing a stake of 20,000 shares — an estimated $6.07M sold.

Clear Street first reported a position in HCA in Q2 2023 and held it in 1 quarter. The position peaked at $6.07M in Q2 2023. 1,000 funds tracked by Wall St. Rank hold HCA as of Q3 2023.

Clear Street reported no remaining HCA Healthcare position as of Q3 2023 after selling out during the quarter.
Clear Street sold 20,000 HCA Healthcare shares in Q3 2023, an estimated $6.07M.
Clear Street first reported a position in HCA Healthcare in Q2 2023 and held it in 1 quarter.
Clear Street's HCA Healthcare position peaked at $6.07M in Q2 2023.
1,000 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2023.

Based on Clear Street's 13F filing for Q3 2023, filed 13 Nov 2023.